SCHEMBL6784089

SCHEMBL6784089

CCOP(COc1ccc2c(c1)c1c(C(=O)NN)cccc1n2Cc1ccc(OC)cc1)OCC

nearest known ligand 0.43

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 15/20 0.43
P2RX4 Q99571 1/20 0.41
TP53 P04637 1/20 0.41
P2RX7 Q99572 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6781791 0.91 P2RX4 (0.43) PLA2G2AP2RX4TP53P2RX7
SCHEMBL6774375 0.75 HTR6 (0.48) PLA2G2A
SCHEMBL6983559 0.73 PLA2G2A (0.59) PLA2G2A
SCHEMBL6774224 0.73 PLA2G2A (0.39) PLA2G2AP2RX7
SCHEMBL6720082 0.72 HTR6 (0.50) PLA2G2A
SCHEMBL6471446 0.69 PIK3R1 (0.47) PLA2G2AP2RX4P2RX7
SCHEMBL6776017 0.68 PLA2G2A (0.48) PLA2G2A
SCHEMBL6472462 0.66 PLA2G2A (0.48) PLA2G2A
SCHEMBL6771322 0.66 EGFR (0.50) PLA2G2A
SCHEMBL6471402 0.66 PDE4B (0.44) PLA2G2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6713645-B1 INHIBITING SPLA2 MEDIATED RELEASE OF FATTY ACIDS FOR TREATMENT OF CONDITIONS SUCH AS SEPTIC SHOCK ELI LILLY AND COMPANY 2004-03-30 US disclosed
EP-0839806-B1 Substituted tricyclics LILLY CO ELI (US) 2003-07-09 EP disclosed
US-6177440-B1 THERAPY FOR SEPSIS SHOCK; PHOSPHOLIPASE INHBITOR ELI LILLY AND COMPANY 2001-01-23 US disclosed
EP-0952149-A2 Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitiors ELI LILLY AND COMPANY (US) 1999-10-27 EP disclosed
WO-1998018464-A1 SUBSTITUTED TRICYCLICS ELI LILLY AND COMPANY (US) 1998-05-07 WO disclosed
EP-0839806-A1 Substituted tricyclics ELI LILLY AND COMPANY (US) 1998-05-06 EP disclosed